Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14326 - 14350 of 14516 in total
Siagoside (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease. It is a naturally occurring substance in the nerve cell’s membrane that is thought to play a role in cell growth, development, and repair. Siagoside completed phase 2 trials for parkinson's disease (PD) treatment. Sygen appears to...
Investigational
Matched Description: … substance in the nerve cell’s membrane that is thought to play a role in cell growth, development, and
Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
Experimental
Investigational
4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Tucaresol has been used in trials studying the treatment of HIV Infections.
Investigational
Experimental
BMS-911543 has been used in trials studying the treatment of Cancer.
Investigational
Saroglitazar has been investigated for the treatment of Fatty Liver.
Investigational
Experimental
Illicit
Experimental
Displaying drugs 14326 - 14350 of 14516 in total